Celularity (CELU) Return on Invested Capital (2022 - 2024)
Celularity (CELU) posted quarterly Return on Invested Capital of 0.04% for Q4 2024, down 2.0% year-over-year from 0.04% in Q1 2024, and down 498.07% quarter-over-quarter from 0.01% in Q3 2024.
Celularity (CELU) Return on Invested Capital (2022 - 2024) Analysis & Trends
Celularity (CELU) has reported Return on Invested Capital for 3 consecutive years, with 0.04% the latest figure, recorded in Q4 2024.
- In Q4 2024, Return on Invested Capital fell 2.0% year-over-year to 0.04%; the TTM figure through Dec 2024 stood at 0.04% (down 2.0% YoY), while the FY2025 annual figure was 0.1%, down 6.0% from the prior year.
- Return on Invested Capital eased to 0.04% in Q4 2024 per CELU's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q4 2022 and bottomed at 0.04% in Q4 2024.
- Historically, Return on Invested Capital has averaged 0.02% across 3 years, with a median of 0.02% in 2023.
- Annual changes were most pronounced in 2023 — Return on Invested Capital declined 2 bps — and 2024, when it rose 1 bps.
- Celularity's Return on Invested Capital stood at 0.0% in 2022, then slumped by 389 bps to 0.02% in 2023, then slumped by 81 bps to 0.04% in 2024.
- Business Quant data shows CELU's Return on Invested Capital at 0.04% in Q4 2024, 0.01% in Q3 2024, and 0.03% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.04% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.03% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |